Abstract：【Objective】T o observe the effect of Maixuekang capsules on quality of life of patients with subacute cerebral infarction.【Methods】Sixty patients with subacute cerebral infarction from January 2015 to January 2016 in our hospital were randomly divided into the control group and the observation group, 30 cases in each group. The control group received conventional treatment such as simvastatin and aspirin, the treatment group received Maixuekang capsule additionally. All were treated for 15 days.The Barthel index (BI) and the modified Rankin scale (mRS) were used to evaluate the daily living ability, prognosis and functional disability of the two groups before and after treatment. The life quality of two groups before and after treatment was evaluated by SS-QOL and SF-36 Health Survey (SF-36).【Results】Before treatment, there was no significant difference between the two groups in BI, mRS score, SS-QOL scale and SF-36 scale score (P＞0.05). After 15d treatment, BI, mRS score, SS-QOL scale and SF-36 scale score of the two groups were better than those before treatment. In the observation group, the BI, mRS score, the SS-QOL scale items like physical activities, language ability, self-care, upper limb function and the SF-36 scores like physiological function, body pain, general health, vitality were improved significantly, the difference was statistically significant (P＜0.05).【Conclusion】Maixuekang capsule can significantly improve the quality of life of patients with subacute cerebral infarction, and is worthy of clinical application.
边莹,杜菊梅,颜江. 脉血康胶囊对亚急性期脑梗死患者生活质量的影响[J]. 医学临床研究, 2017, 34(9): 1681-1683.
BIAN Ying, DU Ju-mei, YAN Jiang. Effect of Maixuekang Capsules on Quality of Life in Patients with Subacute Cerebral Infarction. JOURNAL OF CLINICAL RESEARCH, 2017, 34(9): 1681-1683.
[1]贾建平.神经病学[M].第7版.北京:人民卫生出版社,2013:175. [2]Yan Z,Yu T,Wang Y,et al.Literature review and case report of intravenous thrombolysis in acute cerebral infarction attributed to cervical arterial dissection[J].J Stroke Cerebrovasc Dis,2015,24(9):e265-e269. [3]张素爱.脉血康胶囊治疗急性脑梗死的临床疗效[J].中西医结合心脑血管病杂志,2015,13(13):1549-1551. [4]陈登青.脉血康胶囊对急性脑梗死血液流变学、血脂的影响及临床疗效观察[J].首都医药,2014,21(18):46-47. [5]刘绪宏,许笑天,祝峰,等.脉血康胶囊对急性脑梗死患者血管内皮功能及神经功能评分的影响[J].武警医学,2016,27(3):297-299. [6]边莹,杜菊梅,颜江,等.脉血康胶囊对脑梗死患者亚急性期的疗效研究[J].陕西中医,2016,37(6):703-704. [7]冯容,陈永斌.活血化瘀疗法治疗急性脑梗死研究概述[J].中国中医急症,2016,25(4):668-671. [8]王伟丽,潘志辉,王洪江.糖尿病、脑梗死患者的血液流变学分析[J].内蒙古中医药,2014,33(10):7. [9]Li RY,Cao ZG,Li Y,Wang RT.Increased whole blood viscosity is associated with silent cerebral infarction[J].Clin Hemorheol Microcirc,2015,59(4):301-307. [10]Zhou L,Guo SN,Gao Y.Effects and perspectives of Chinese patient medicines for tonifying qi and promoting blood circulation on patients with cerebral infarction[J].Curr Vasc Pharmacol,2015,13(4):475-491. [11]Cortez MM,Wilder MJ,McFadden M,et al.Quality of life after intra-arterial therapy for acute ischemic stroke[J].J Stroke Cerebrovasc Dis,2014,23(7):1890-1896. [12]谭必春.影响急性脑梗死患者治疗效果的相关因素分析[J].中国临床研究,2014,27(3):283-284.
2017, Vol. 34 
